S. 3788, the CLEAR LABELS Act, advanced out of committee on July 22, 2026.
S. 3788 — CLEAR LABELS Act
What it does
This bill requires drug manufacturers to clearly label medications with the name, location, and facility ID of the original manufacturer and supply chain participants—either on the package or via QR code/barcode linking to an online database. It also exempts these drug labels from separate customs country-of-origin marking rules, streamlining compliance. The goal is to give patients and regulators visibility into where drugs actually come from.
Quorum's transparency scan gave CLEAR LABELS Act a moderate transparency flag.
What happens next
S. 3788 advanced out of committee. Next stop: a floor vote.
Who is behind it
Filed by Rick Scott. Cosponsored by Alan Armstrong, Ashley Moody, Chuck Grassley and James Risch.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.